{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:59:00Z","timestamp":1790279940771,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16479-0","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:05:43Z","timestamp":1783695943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uncovering the mechanism of DCLK3 in colorectal cancer progression through WGCNA and machine learning"],"prefix":"10.1186","volume":"26","author":[{"given":"Lu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"16479_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jconrel.2023.09.014","volume":"362","author":"Q Pan","year":"2023","unstructured":"Pan Q, Fan X, Xie L, Wu D, Liu R, Gao W, Luo K, He B, Pu Y. Nano-enabled colorectal cancer therapy. J controlled release: official J Controlled Release Soc. 2023;362:548\u201364.","journal-title":"J controlled release: official J Controlled Release Soc"},{"issue":"12","key":"16479_CR2","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.3390\/genes13122326","volume":"13","author":"S Hryhorowicz","year":"2022","unstructured":"Hryhorowicz S, Kaczmarek-Ry\u015b M. Strong Hereditary Predispositions to Colorectal Cancer. Genes. 2022;13(12):2326.","journal-title":"Genes"},{"key":"16479_CR3","doi-asserted-by":"crossref","unstructured":"Ionescu VA, Gheorghe G, Baban IA, Barbu A, Georgescu TF, Tiuca LC, Iacobus NA, Diaconu CC. Prognostic Differences Between Early-Onset and Late-Onset Colorectal Cancer. Med (Kaunas Lithuania). 2025;61(3):390.","DOI":"10.3390\/medicina61030390"},{"issue":"6","key":"16479_CR4","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.3390\/curroncol28060447","volume":"28","author":"K Chen","year":"2021","unstructured":"Chen K, Collins G, Wang H, Toh JWT. Pathological Features and Prognostication in Colorectal Cancer. Curr Oncol (Toronto Ont). 2021;28(6):5356\u201383.","journal-title":"Curr Oncol (Toronto Ont)"},{"issue":"4","key":"16479_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/0118744710331660250127115004","volume":"18","author":"B Ensiyeh","year":"2025","unstructured":"Ensiyeh B, Yazdan Z, Ali H, Manijeh J, Sahar M. Role of the p53\/miR-34a\/SIRT1 Feedback Loop in Metformin-induced Radiosensitivity of Colorectal Cancer Cells. Curr Radiopharmaceuticals. 2025;18(4):340\u201351.","journal-title":"Curr Radiopharmaceuticals"},{"issue":"5","key":"16479_CR6","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/brain\/awy057","volume":"141","author":"L Galvan","year":"2018","unstructured":"Galvan L, Francelle L, Gaillard MC, de Longprez L, Carrillo-de Sauvage MA, Liot G, Cambon K, Stimmer L, Luccantoni S, Flament J, et al. The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin. Brain. 2018;141(5):1434\u201354.","journal-title":"Brain"},{"issue":"10","key":"16479_CR7","doi-asserted-by":"publisher","first-page":"110664","DOI":"10.1016\/j.jbc.2025.110664","volume":"301","author":"JD Lu","year":"2025","unstructured":"Lu JD, Zhao P, Prasad A, Gupta N, Gravel N, Shidhaye T, Wells L, Katiyar S, Kannan N. Deciphering the unique autoregulatory mechanisms and substrate specificity of the understudied DCLK3 kinase linked to neurodegenerative diseases. J Biol Chem. 2025;301(10):110664.","journal-title":"J Biol Chem"},{"issue":"7","key":"16479_CR8","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1093\/brain\/awaf042","volume":"148","author":"L de Longprez","year":"2025","unstructured":"de Longprez L, Gaillard MC, Decraene C, P\u00e9rot JB. Loss of the neuronal kinase DCLK3 leads to anxiety-like behaviour and memory deficits. Brain. 2025;148(7):2453\u201368.","journal-title":"Brain"},{"issue":"1","key":"16479_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11845-023-03430-6","volume":"193","author":"J Cheng","year":"2024","unstructured":"Cheng J, Tang YC, Dong Y, Qin RL, Dong ZQ. Doublecortin-like kinase 3 (DCLK3) is associated with bad clinical outcome of patients with gastric cancer and regulates the ferroptosis and mitochondria function in vitro and in vivo. Ir J Med Sci. 2024;193(1):35\u201343.","journal-title":"Ir J Med Sci"},{"key":"16479_CR10","doi-asserted-by":"publisher","first-page":"14418","DOI":"10.1038\/ncomms14418","volume":"8","author":"NQ Liu","year":"2017","unstructured":"Liu NQ, Ter Huurne M, Nguyen LN, Peng T, Wang SY, Studd JB. The non-coding variant rs1800734 enhances DCLK3 expression through long-range interaction and promotes colorectal cancer progression. Nat Commun. 2017;8:14418.","journal-title":"Nat Commun"},{"key":"16479_CR11","doi-asserted-by":"crossref","unstructured":"Kalampounias G, Androutsopoulou T. Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. Cells. 2025;14(16):1257.","DOI":"10.3390\/cells14161257"},{"issue":"7","key":"16479_CR12","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.18632\/aging.102991","volume":"12","author":"H Zhao","year":"2020","unstructured":"Zhao H, Chen M, Wang J, Cao G, Chen W, Xu J. PCNA-associated factor KIAA0101 transcriptionally induced by ELK1 controls cell proliferation and apoptosis in nasopharyngeal carcinoma: an integrated bioinformatics and experimental study. Aging. 2020;12(7):5992\u20136017.","journal-title":"Aging"},{"key":"16479_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.2147\/OTT.S98727","volume":"9","author":"Q Yan","year":"2016","unstructured":"Yan Q, Lou G, Qian Y, Qin B, Xu X, Wang Y, Liu Y, Dong X. SPAG9 is involved in hepatocarcinoma cell migration and invasion via modulation of ELK1 expression. OncoTargets therapy. 2016;9:1067\u201375.","journal-title":"OncoTargets therapy"},{"key":"16479_CR14","doi-asserted-by":"crossref","unstructured":"Zhao L, Wang Y, Sun X, Zhang X, Simone N. ELK1\/MTOR\/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer. Int J Mol Sci. 2024;25(4):2382.","DOI":"10.3390\/ijms25042382"},{"issue":"10","key":"16479_CR15","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1097\/MS9.0000000000002256","volume":"86","author":"X Xu","year":"2024","unstructured":"Xu X, Wang Y, Wang Q, Lv S, Mao G. Elevated expression of ELK1 promotes breast cancer cell growth and correlates with poor prognosis of breast cancer patients. Annals Med Surg (2012). 2024;86(10):5767\u201375.","journal-title":"Annals Med Surg (2012)"},{"issue":"12","key":"16479_CR16","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/mc.23627","volume":"62","author":"Q Chen","year":"2023","unstructured":"Chen Q, Fu Y. Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer. Mol Carcinog. 2023;62(12):1947\u201359.","journal-title":"Mol Carcinog"},{"issue":"1","key":"16479_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1186\/s12885-022-09986-3","volume":"22","author":"S Wei","year":"2022","unstructured":"Wei S, Yu Z, Shi R, An L, Zhang Q, Zhang Q, Zhang T, Zhang J, Wang H. GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1. BMC Cancer. 2022;22(1):881.","journal-title":"BMC Cancer"},{"key":"16479_CR18","doi-asserted-by":"publisher","first-page":"164202","DOI":"10.1016\/j.cej.2025.164202","volume":"516","author":"W Luo","year":"2025","unstructured":"Luo W, Pan X, Ren C, Wang T, Li G, Jin L, Zhang D. Anti-swelling and ROS-scavenging nanofiber hydrogel to prevent postoperative abdominal adhesion. Chem Eng J. 2025;516:164202.","journal-title":"Chem Eng J"},{"key":"16479_CR19","doi-asserted-by":"publisher","first-page":"167519","DOI":"10.1016\/j.cej.2025.167519","volume":"522","author":"X Pan","year":"2025","unstructured":"Pan X, Zhu P, Ding Y, Di C, Yang Z, Zhou H, Li C, Jin L. Engineered honeysuckle extracellular vesicles loaded in ROS response hydrogel for inhibition of postoperative abdominal adhesion. Chem Eng J. 2025;522:167519.","journal-title":"Chem Eng J"},{"key":"16479_CR20","doi-asserted-by":"crossref","unstructured":"Adeleke A, Adebayo AS. Colorectal Cancer: Therapeutic Approaches and Their Complications. Biomedicines. 2025;13(7).","DOI":"10.3390\/biomedicines13071646"},{"issue":"1","key":"16479_CR21","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12866-021-02274-3","volume":"21","author":"S Ebrahimzadeh","year":"2021","unstructured":"Ebrahimzadeh S, Ahangari H, Soleimanian A, Hosseini K, Ebrahimi V, Ghasemnejad T, Soofiyani SR, Tarhriz V. Colorectal cancer treatment using bacteria: focus on molecular mechanisms. BMC Microbiol. 2021;21(1):218.","journal-title":"BMC Microbiol"},{"key":"16479_CR22","doi-asserted-by":"crossref","unstructured":"O\u2019Reilly M, Linehan A, Krstic A, Kolch W. Oncotherapeutic Strategies in Early Onset Colorectal Cancer. Cancers 2023;15(2).","DOI":"10.3390\/cancers15020552"},{"issue":"9","key":"16479_CR23","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00432-017-2438-y","volume":"143","author":"H Mothes","year":"2017","unstructured":"Mothes H, Bauschke A, Schuele S, Eigendorff E, Altendorf-Hofmann A, Settmacher U. Surgery for colorectal cancer in elderly patients: how can we improve outcome? J Cancer Res Clin Oncol. 2017;143(9):1879\u201389.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"16479_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1101\/gr.193169.115","volume":"26","author":"D Hollander","year":"2016","unstructured":"Hollander D, Donyo M, Atias N, Mekahel K, Melamed Z, Yannai S, Lev-Maor G, Shilo A, Schwartz S, Barshack I, et al. A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1. Genome Res. 2016;26(4):541\u201353.","journal-title":"Genome Res"},{"issue":"1","key":"16479_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12032-021-01607-6","volume":"39","author":"S Wang","year":"2021","unstructured":"Wang S, Zhang H, Liu H, Guo X, Ma R, Zhu W, Gao P. ELK1-induced up-regulation of KIF26B promotes cell cycle progression in breast cancer. Med Oncol (Northwood Lond Engl). 2021;39(1):15.","journal-title":"Med Oncol (Northwood Lond Engl)"},{"issue":"8","key":"16479_CR26","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1111\/jog.15710","volume":"49","author":"B Yang","year":"2023","unstructured":"Yang B, Wang H, Xiao J, Chen W, Chen W. ELK1\/KIFC1 axis promotes breast cancer cell proliferation by regulating glutathione metabolism. J Obstet Gynaecol Res. 2023;49(8):2175\u201384.","journal-title":"J Obstet Gynaecol Res"},{"issue":"14","key":"16479_CR27","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1038\/s41388-020-1199-2","volume":"39","author":"R Yang","year":"2020","unstructured":"Yang R, Li X, Wu Y, Zhang G, Liu X, Li Y, Bao Y, Yang W. EGFR activates GDH1 transcription to promote glutamine metabolism through MEK\/ERK\/ELK1 pathway in glioblastoma. Oncogene. 2020;39(14):2975\u201386.","journal-title":"Oncogene"},{"key":"16479_CR28","doi-asserted-by":"crossref","unstructured":"Yu TT, Zhang T, Su F, Li YL, Shan L, Hou XM. ELK1 Promotes Epithelial-Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregulating B7-H3. Oxidative medicine and cellular longevity. 2021:2805576.","DOI":"10.1155\/2021\/2805576"},{"key":"16479_CR29","doi-asserted-by":"publisher","first-page":"1790936","DOI":"10.3389\/fimmu.2026.1790936","volume":"17","author":"Z Liu","year":"2026","unstructured":"Liu Z, Liu J, Chu H, Lu Z, Xu S, Qin Y, Zhao L, Zhang C. JAK inhibition in PD-1 immunotherapy and tumor microenvironment. Front Immunol. 2026;17:1790936.","journal-title":"Front Immunol"},{"key":"16479_CR30","doi-asserted-by":"crossref","unstructured":"Wang P, Xu S, Guo Q, Zhao Y. Discovery of PAK2 as a Key Regulator of Cancer Stem Cell in Head and Neck Squamous Cell Carcinoma Using Multi-Omic Techniques. Stem Cells Int. 2025:1325262.","DOI":"10.1155\/sci\/1325262"},{"key":"16479_CR31","doi-asserted-by":"publisher","first-page":"1678907","DOI":"10.3389\/fimmu.2025.1678907","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Lu K, Xu Y, Xu S, Chu H, Fang X. Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies. Front Immunol. 2025;16:1678907.","journal-title":"Front Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16479-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16479-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16479-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:03:41Z","timestamp":1790276621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16479-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16479"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16479-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All human disease tissue research was approved by the Institutional Review Board of The First Affiliated Hospital of Henan University of Medicine, and complied with the Declaration of Helsinki. Written informed consent was obtained from all patients, and all samples were de-identified to protect patient privacy.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All nude mouse xenograft experiments were approved by the Institutional Animal Care and Use Committee of The First Affiliated Hospital of Henan University of Medicine. Animal procedures followed the ARRIVE guidelines and 3Rs principle. Anesthesia was used in all surgeries, and humane euthanasia was applied to reduce animal distress, which fully complied with relevant ethical standards.","order":3,"name":"Ethics","label":"Animal studies","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1138"}}